1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Patología Molecular del Cáncer

Patología Molecular del Cáncer

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Gayarre J, Martín-Gimeno P, Osorio A, Paumard B, Barroso A, Fernández V, de la Hoya M, Rojo A, Caldés T, Palacios J, Urioste M, Benítez J, García MJ.

    Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.

    BRITISH JOURNAL OF CANCER . 117(7): 1048-1062. Nº de citas: 6

    [doi:10.1038/bjc.2017.286]

  • Garrido P, Olmedo ME, Gómez A, Paz Ares L, López-Ríos F, Rosa-Rosa JM, Palacios J.

    Treating KRAS -mutant NSCLC: latest evidence and clinical consequences.

    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY . 9(9): 589-597. Nº de citas: 26

    [doi:10.1177/1758834017719829]

  • Espinosa I, Lee CH, D'Angelo E, Palacios J, Prat J.

    Undifferentiated and Dedifferentiated Endometrial Carcinomas With POLE Exonuclease Domain Mutations Have a Favorable Prognosis.

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY . 41(8): 1121-1128. Nº de citas: 49

    [doi:10.1097/PAS.0000000000000873]

  • Vaca M, Polo R, Martínez-San-Millán J, Reguero ME, Pérez C, Cordero A, Medina MD, Cobeta I.

    Pigmented Villonodular Synovitis of the Temporomandibular Joint With Petrous Bone Invasion.

    OTOLOGY & NEUROTOLOGY . 38(5): . Nº de citas: 3

    [doi:10.1097/MAO.0000000000001390]

  • Quintela-Fandino M, Lluch A, Manso LM, Calvo I, Cortes J, García-Saenz JA, Gil JM, Martinez-Jañez N, González-Martín A, Adrover E, De Andres R, Viñas G, Llombart Cussac A, Alba E, Guerra J, Bermejo B, Zamora E, Moreno-Anton F, Pernas-Simon S, Carrato A, Lopez A, Escudero MJ, Campo R, Carrasco EM, Palacios J, Mulero F, Colomer R.

    18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.

    CLINICAL CANCER RESEARCH . 23(6): 1432-1441. Nº de citas: 21

    [doi:10.1158/1078-0432.CCR-16-0738]

  • Devis L, Moiola CP, Masia N, Martinez-Garcia E, Santacana M, Stirbat TV, Brochard-Wyart F, García Á, Alameda F, Cabrera S, Palacios J, Moreno-Bueno G, Abal M, Thomas W, Dufour S, Matias-Guiu X, Santamaria A, Reventos J, Gil-Moreno A, Colas E.

    Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.

    JOURNAL OF PATHOLOGY . 241(4): 475-487. Nº de citas: 32

    [doi:10.1002/path.4851]

  • Vaz Salgado MA, Soto M, Reguero ME, Muñoz G, Cabañero A, Gallego I, Resano S, Longo F, Madariaga A, Gomez A, Carrato A.

    Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients.

    CLINICAL & TRANSLATIONAL ONCOLOGY . 19(3): 357-363. Nº de citas: 7

    [doi:10.1007/s12094-016-1536-7]

  • Martínez-Iglesias O, Olmeda D, Alonso-Merino E, Gómez-Rey S, González-López AM, Luengo E, Soengas MS, Palacios J, Regadera J, Aranda A.

    The nuclear corepressor 1 and the thyroid hormone receptor ß suppress breast tumor lymphangiogenesis.

    Oncotarget . 7(48): 78971-78984. Nº de citas: 1

    [doi:10.18632/oncotarget.12978]

  • Rosa-Rosa JM, Leskelä S, Cristóbal-Lana E, Santón A, López-García MÁ, Muñoz G, Pérez-Mies B, Biscuola M, Prat J, Esther OE, Soslow RA, Matias-Guiu X, Palacios J.

    Molecular genetic heterogeneity in undifferentiated endometrial carcinomas.

    MODERN PATHOLOGY . 29(11): 1390-1398. Nº de citas: 47

    [doi:10.1038/modpathol.2016.132]

  • Aldecoa I, Atares B, Tarragona J, Bernet L, Sardon JD, Pereda T, Villar C, Mendez MC, Gonzalez-Obeso E, Elorriaga K, Alonso GL, Zamora J, Planell N, Palacios J, Castells A, Matias-Guiu X, Cuatrecasas M.

    Molecularly determined total tumour load in lymph nodes of stage I-II colon cancer patients correlates with high-risk factors. A multicentre prospective study.

    VIRCHOWS ARCHIV . 469(4): 385-394. Nº de citas: 16

    [doi:10.1007/s00428-016-1990-1]

  • Hergueta-Redondo M, Sarrio D, Molina-Crespo Á, Vicario R, Bernadó-Morales C, Martínez L, Rojo-Sebastián A, Serra-Musach J, Mota A, Martínez-Ramírez Á, Castilla MÁ, González-Martin A, Pernas S, Cano A, Cortes J, Nuciforo PG, Peg V, Palacios J, Pujana MÁ, Arribas J, Moreno-Bueno G.

    Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer.

    Oncotarget . 7(35): 56295-56308. Nº de citas: 45

    [doi:10.18632/oncotarget.10787]

  • Vieites B, López-García MA, Castilla C, Hernández MJ, Biscuola M, Alfaro L, Atienza, Castilla MA, Palacios J.

    CK19 expression in breast tumours and lymph node metastasis after neoadjuvant therapy

    Histopathology . 69(2): 239-249. Nº de citas: 4

    [doi:10.1111/his.12924]

  • Gorospe L, Cabañero-Sánchez A, Muñoz-Molina GM, Olmedo-García ME, Hernanz de Lucas R, García-Cosío M.

    Primary Mediastinal Germ Cell Tumor Containing an Angiosarcomatous Component.

    ANNALS OF THORACIC SURGERY . 102(1): 63-63. Nº de citas: 1

    [doi:10.1016/j.athoracsur.2016.01.101]

  • Espinosa I, D'Angelo E, Palacios J, Prat J.

    Mixed and Ambiguous Endometrial Carcinomas: A Heterogenous Group of Tumors With Different Clinicopathologic and Molecular Genetic Features.

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY . 40(7): 972-981. Nº de citas: 24

    [doi:10.1097/PAS.0000000000000640]

  • Schultheis AM, Ng CK, De Filippo MR, Piscuoglio S, Macedo GS, Gatius S, Perez Mies B, Soslow RA, Lim RS, Viale A, Huberman KH, Palacios JC, Reis-Filho JS, Matias-Guiu X, Weigelt B.

    Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.

    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE . 108(6): . Nº de citas: 107

    [doi:10.1093/jnci/djv427]

  • Hmadcha A, Aguilera Y, Lozano-Arana MD, Mellado N, Sánchez J, Moya C, Sánchez-Palazón L, Palacios J, Antiñolo G, Soria B.

    Derivation of HVR1, HVR2 and HVR3 human embryonic stem cell lines from IVF embryos after preimplantation genetic diagnosis (PGD) for monogenic disorder.

    STEM CELL RESEARCH . 16(3): 635-639. Nº de citas: 1

    [doi:10.1016/j.scr.2016.03.012]

  • Ferrer I, Verdugo-Sivianes EM, Castilla MA, Melendez R, Marin JJ, Muñoz-Galvan S, Lopez-Guerra JL, Vieites B, Ortiz-Gordillo MJ, De León JM, Praena-Fernandez JM, Perez M, Palacios J, Carnero A.

    Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors

    Oncogene . 35(21): 2777-2788. Nº de citas: 21

    [doi:10.1038/onc.2015.341]

  • Alba E, Lluch A, Ribelles N, Anton-Torres A, Sanchez-Rovira P, Albanell J, Calvo L, García-Asenjo JA, Palacios J, Chacon JI, Ruiz A, De la Haba-Rodriguez J, Segui-Palmer MA, Cirauqui B, Margeli M, Plazaola A, Barnadas A, Casas M, Caballero R, Carrasco E, Rojo F.

    High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.

    ONCOLOGIST . 21(2): 150-155. Nº de citas: 21

    [doi:10.1634/theoncologist.2015-0312]